Cohen M P, Lautenslager G T, Shearman C W
IMR, University City Science Center, Philadelphia, Pennsylvania 19104, USA.
Diabetes Care. 2001 May;24(5):914-8. doi: 10.2337/diacare.24.5.914.
Increased albumin excretion in diabetes is believed to be derived from hemodynamic and/or permeability abnormalities, whereas mesangial matrix expansion gives rise to the reduction in glomerular filtration surface and decline in renal function in diabetic nephropathy. We postulated that the overproduction of extracellular matrix proteins underlying glomerulosclerosis in diabetes might be associated with the excretion of increased amounts of type IV collagen in the urine.
To explore this hypothesis, we measured the urinary excretion of (human) collagen IV by immunoassay in 65 patients with type 1 or type 2 diabetes and various degrees of albuminuria and examined its relationship to filtration function assessed by the reciprocal of the serum creatinine (RSC).
Collagen IV excretion showed a significant (P < 0.001) inverse correlation (r = -0.62) with the RSC, and this correlation pertained regardless of whether albumin cxcretion was in the low (< or =< or = 100 microg/mg creatinine r = -0.73) or high (>100 microg/mg; r = -0.53) range. In contrast, albumin excretion showed insignificant correlation with either collagen IV excretion (r = 0.12) or with the RSC (r = -0.20). Urinary collagen IV was significantly higher (P < 0.05) in patients with an RSC value < or = 100 (28.3 +/- 2.4 ng/mg creatinine) than in patients with an RSC value > 100 (16.0 +/- 0.8 ng/mg creatinine).
Because not all patients with microalbuminuria progress to declining renal function and some patients who develop nephropathy do not manifest albuminuria, the findings in this cross-sectional analysis suggest that measurement of urine collagen IV may be a useful noninvasive indicator to detect diabetic renal disease entering a phase of compromised renal function.
糖尿病患者白蛋白排泄增加被认为源于血流动力学和/或通透性异常,而系膜基质扩张会导致糖尿病肾病患者肾小球滤过面积减少和肾功能下降。我们推测,糖尿病肾小球硬化症背后细胞外基质蛋白的过度产生可能与尿中IV型胶原排泄量增加有关。
为探究这一假设,我们采用免疫分析法测量了65例1型或2型糖尿病且伴有不同程度蛋白尿患者的(人)IV型胶原尿排泄量,并研究了其与通过血清肌酐倒数(RSC)评估的滤过功能之间的关系。
IV型胶原排泄量与RSC呈显著负相关(P<0.001,r=-0.62),无论白蛋白排泄处于低水平(≤100μg/mg肌酐;r=-0.73)还是高水平(>100μg/mg;r=-0.53),这种相关性均成立。相比之下,白蛋白排泄量与IV型胶原排泄量(r=0.12)或RSC(r=-0.20)之间的相关性不显著。RSC值≤100的患者(28.3±2.4ng/mg肌酐)尿IV型胶原显著高于RSC值>100的患者(16.0±0.8ng/mg肌酐)(P<0.05)。
由于并非所有微量白蛋白尿患者都会进展至肾功能下降,且一些发生肾病的患者并未出现白蛋白尿,因此这项横断面分析的结果表明,测量尿IV型胶原可能是检测进入肾功能受损阶段的糖尿病肾病的一种有用的非侵入性指标。